Cargando…
COVID-19 Control: Can Germany Learn From China?
The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719213/ https://www.ncbi.nlm.nih.gov/pubmed/32610735 http://dx.doi.org/10.34172/ijhpm.2020.78 |
_version_ | 1783619633750736896 |
---|---|
author | Müller, Olaf Lu, Guangyu Jahn, Albrecht Razum, Oliver |
author_facet | Müller, Olaf Lu, Guangyu Jahn, Albrecht Razum, Oliver |
author_sort | Müller, Olaf |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an early stage. The epicentre of the pandemic has since shifted to Europe and The Americas. In certain cities and regions, health systems became overwhelmed by high numbers of cases and deaths, whereas other regions continue to experience low incidence rates. Still, lockdowns were usually implemented country-wide, albeit with differing intensities between countries. Compared to its neighbours, Germany has managed to keep the epidemic relatively well under control, in spite of a lockdown that was only partial. In analogy to many countries at a similar stage, Germany is now under increasing pressure to further relax lockdown measures to limit economic and psychosocial costs. However, if this is done too rapidly, Germany risks facing tens of thousands more severe cases of COVID-19 and deaths in the coming months. Hence, it could again follow China’s example and relax measures according to local incidence, based on intensive testing. |
format | Online Article Text |
id | pubmed-7719213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-77192132020-12-09 COVID-19 Control: Can Germany Learn From China? Müller, Olaf Lu, Guangyu Jahn, Albrecht Razum, Oliver Int J Health Policy Manag Perspective The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an early stage. The epicentre of the pandemic has since shifted to Europe and The Americas. In certain cities and regions, health systems became overwhelmed by high numbers of cases and deaths, whereas other regions continue to experience low incidence rates. Still, lockdowns were usually implemented country-wide, albeit with differing intensities between countries. Compared to its neighbours, Germany has managed to keep the epidemic relatively well under control, in spite of a lockdown that was only partial. In analogy to many countries at a similar stage, Germany is now under increasing pressure to further relax lockdown measures to limit economic and psychosocial costs. However, if this is done too rapidly, Germany risks facing tens of thousands more severe cases of COVID-19 and deaths in the coming months. Hence, it could again follow China’s example and relax measures according to local incidence, based on intensive testing. Kerman University of Medical Sciences 2020-05-27 /pmc/articles/PMC7719213/ /pubmed/32610735 http://dx.doi.org/10.34172/ijhpm.2020.78 Text en © 2020 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspective Müller, Olaf Lu, Guangyu Jahn, Albrecht Razum, Oliver COVID-19 Control: Can Germany Learn From China? |
title | COVID-19 Control: Can Germany Learn From China? |
title_full | COVID-19 Control: Can Germany Learn From China? |
title_fullStr | COVID-19 Control: Can Germany Learn From China? |
title_full_unstemmed | COVID-19 Control: Can Germany Learn From China? |
title_short | COVID-19 Control: Can Germany Learn From China? |
title_sort | covid-19 control: can germany learn from china? |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719213/ https://www.ncbi.nlm.nih.gov/pubmed/32610735 http://dx.doi.org/10.34172/ijhpm.2020.78 |
work_keys_str_mv | AT mullerolaf covid19controlcangermanylearnfromchina AT luguangyu covid19controlcangermanylearnfromchina AT jahnalbrecht covid19controlcangermanylearnfromchina AT razumoliver covid19controlcangermanylearnfromchina |